Once-a-week versus once-every-3-weeks cisplatin in patients receiving chemoradiation for locally advanced head-and-neck cancer: A survey of practice in India

Once-a-week versus once-every-3-weeks cisplatin in patients receiving chemoradiation for locally advanced head-and-neck cancer: A survey of practice in India

Purpose: High-dose (100 mg/m2) cisplatin with radiotherapy is the standard practice in locally advanced head-and-neck squamous cell carcinoma. Use of this regimen in resource- constrained and economically constrained countries like India is difficult. Methods: This study was a cross-sectional survey...

Full description

Bibliographic Details
Main Authors: Gautam Goyal, Vijay M Patil, Vanita Noronha, Amit Joshi, Satvik Khaddar, Sajak Kakkar, Ritesh Pruthy, Purvish Parikh, Kumar Prabhash
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Cancer Research, Statistics, and Treatment
Subjects:
chemoradiation
cisplatin
concurrent chemoradiation
concurrent chemotherapy
head-and-neck cancer
once-a-week
once-every-3-weeks
radiotherapy
survey
Online Access:http://www.crstonline.com/article.asp?issn=2590-3233;year=2018;volume=1;issue=1;spage=63;epage=67;aulast=

Internet

http://www.crstonline.com/article.asp?issn=2590-3233;year=2018;volume=1;issue=1;spage=63;epage=67;aulast=

Similar Items